Ancient Heart Drug Enters Clinical Trial as Potential Treatment for Deadly Pancreatic Cancer
A heart medicine first prescribed in the 18th century is now being tested as a potential treatment for pancreatic cancer — one of the deadliest forms of cancer worldwide. Researchers at the University of Skövde and Skaraborg Hospital in Sweden are launching a clinical trial to evaluate the effects of digitoxin, a well-known cardiac drug derived from the foxglove plant.